Fact CheckerSign in

NCT03716128Recruiting

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function Can 18F-PET Replace Bone Histomorphometry

Source: ClinicalTrials.gov · Last updated 18 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of the study is to 1. To describe the bone morphology in patients with reduced renal function and high or low parathyroid hormone (PTH) respectively. 2. To investigate if the non-invasive method 18-Fluoride Positron Emission Tomography (18F-PET) can describe the bone turnover and reflect the bone histomorphologic changes 3. To investigate if non-oxidized PTH reflects bone turnover

Status (registry)
Recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
26 Sept 2018
Start date
26 Sept 2018
Primary completion date
Oct 2027
Lead sponsor
Ditte Hansen
NCT number
NCT03716128

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 26 Sept 2018 to the primary completion date, Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • ongoing malignancy
  • Allergy towards tetracyclin

Other

  • Pregnancy
    • Control Group:

Who the study is looking for

  • -≥ 18 years
  • estimated Glomerular Filtration Rate (eGFR) ≤ 20 ml/min/1,73m2
  • PTH \< 150 pg/ml or PTH \> 300 pg/ml
  • -≥ 18 years
  • eGFR \>= 60 ml/min
  • under examination for c prostata
  • Prostatic Specific Antigen (PSA) total \<40 µg/l
    • Exclusion:
  • Former kidney disease
  • ionized calcium or PTH outside normal range
  • Known metabolic bone disease
  • treatment with anticoagulants
  • Disturbed thrombosis and hemostasis

Criteria the registry did not label

  • Patients with reduced renal function:

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Herlev Hospital
Coordinator of this site? Confirm its status
HerlevDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.